Title: Topical bromfenac as an adjunctive treatment with intravitreal ranibizumab for exudative age-related macular degeneration.
Journal: Retina (Philadelphia, Pa.) 20121001
Title: Acute corneal melt associated with topical bromfenac use.
Journal: Eye & contact lens 20120701
Title: Prospective randomized controlled trial of combination ranibizumab (Lucentis) and bromfenac (Xibrom) for neovascular age-related macular degeneration: a pilot study.
Journal: Retina (Philadelphia, Pa.) 20120301
Title: A randomized comparison of to-aqueous penetration of ketorolac 0.45%, bromfenac 0.09% and nepafenac 0.1% in cataract patients undergoing phacoemulsification.
Journal: Current medical research and opinion 20111201
Title: Prostaglandin E2 inhibition of ketorolac 0.45%, bromfenac 0.09%, and nepafenac 0.1% in patients undergoing phacoemulsification.
Journal: Advances in therapy 20111201
Title: Inflammation after phakic implants.
Journal: Ophthalmology 20111201
Title: Safety and efficacy of bromfenac ophthalmic solution (Bromday) dosed once daily for postoperative ocular inflammation and pain.
Journal: Ophthalmology 20111101
Title: NSAIDs inhibit neovascularization of choroid through HO-1-dependent pathway.
Journal: Laboratory investigation; a journal of technical methods and pathology 20110901
Title: Once daily dosing of bromfenac ophthalmic solution 0.09% for postoperative ocular inflammation and pain.
Journal: Current medical research and opinion 20110901
Title: Ocular penetration and anti-inflammatory activity of ketorolac 0.45% and bromfenac 0.09% against lipopolysaccharide-induced inflammation.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20110401
Title: Pharmacokinetic comparisons of bromfenac in DuraSite and Xibrom.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20110201
Title: Efficacy of bromfenac sodium ophthalmic solution in preventing cystoid macular oedema after cataract surgery in patients with diabetes.
Journal: Acta ophthalmologica 20101201
Title: Efficacy and safety of bromfenac for the treatment of corneal ulcer pain.
Journal: Advances in therapy 20101001
Title: NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema.
Journal: Retina (Philadelphia, Pa.) 20100201
Title: Ophthalmic utility of topical bromfenac, a twice-daily nonsteroidal anti-inflammatory agent.
Journal: Expert opinion on pharmacotherapy 20091001
Title: Differential effects of non-steroidal anti-inflammatory drugs on mitochondrial dysfunction during oxidative stress.
Journal: Archives of biochemistry and biophysics 20091001
Title: Vitreous nonsteroidal antiinflammatory drug concentrations and prostaglandin E2 levels in vitrectomy patients treated with ketorolac 0.4%, bromfenac 0.09%, and nepafenac 0.1%.
Journal: Retina (Philadelphia, Pa.) 20091001
Title: Efficacy of ophthalmic nonsteroidal antiinflammatory drugs in suppressing anterior capsule contraction and secondary posterior capsule opacification.
Journal: Journal of cataract and refractive surgery 20090901
Title: Concentration and dosing of ketorolac versus bromfenac.
Journal: Journal of cataract and refractive surgery 20090701
Title: Comparison of efficacy of bromfenac sodium 0.1% ophthalmic solution and fluorometholone 0.02% ophthalmic suspension for the treatment of allergic conjunctivitis.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20090601
Title: Aqueous prostaglandin E(2) of cataract patients at trough ketorolac and bromfenac levels after 2 days dosing.
Journal: Advances in therapy 20090601
Title: Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery.
Journal: Acta ophthalmologica 20090501
Title: Cyclooxygenase (COX)-inhibiting drug reduces HSV-1 reactivation in the mouse eye model.
Journal: Current eye research 20090301
Title: Topical bromfenac 0.09% vs. ketorolac 0.4% for the control of pain, photophobia, and discomfort following PRK.
Journal: Journal of refractive surgery (Thorofare, N.J. : 1995) 20090201
Title: Retrospective review of the efficacy of topical bromfenac (0.09%) as an adjunctive therapy for patients with neovascular age-related macular degeneration.
Journal: Retina (Philadelphia, Pa.) 20090101
Title: Ocular pharmacokinetics of a single dose of bromfenac sodium ophthalmic solution 0.1% in human aqueous humor.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20081201
Title: Comparison of ketorolac 0.4% and bromfenac 0.09% at trough dosing: aqueous drug absorption and prostaglandin E2 levels.
Journal: Journal of cataract and refractive surgery 20080901
Title: Re: Pharmacokinetics and pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac.
Journal: Journal of cataract and refractive surgery 20080801
Title: 24-hour evaluation of the ocular distribution of (14)C-labeled bromfenac following topical instillation into the eyes of New Zealand White rabbits.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20080801
Title: The systemic safety of bromfenac ophthalmic solution 0.09%.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20071201
Title: Bromfenac ophthalmic solution 0.09% (Xibrom) for postoperative ocular pain and inflammation.
Journal: Ophthalmology 20070901
Title: In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac.
Journal: Journal of cataract and refractive surgery 20070901
Title: Corneal melting and perforation in Stevens Johnson syndrome following topical bromfenac use.
Journal: Journal of cataract and refractive surgery 20070901
Title: Effect of ophthalmic solution components on acrylic intraocular lenses.
Journal: Journal of cataract and refractive surgery 20070101
Title: Topical bromfenac sodium for long-term management of vernal keratoconjunctivitis.
Journal: Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 20070101
Title: Effects of nonsteroidal ophthalmic drops on epithelial healing and pain in patients undergoing bilateral photorefractive keratectomy (PRK).
Journal: Advances in therapy 20070101
Title: Misuse and abuse of topically applied nonsteroidal anti-inflammatory drugs.
Journal: Cornea 20061201
Title: Three cases of corneal melting after instillation of a new nonsteroidal anti-inflammatory drug.
Journal: Cornea 20061201
Title: Hepatic disorders in patients treated with COX-2 selective inhibitors or nonselective NSAIDs: a case/noncase analysis of spontaneous reports.
Journal: Clinical therapeutics 20060801
Title: Effects of an opioid (oxycodone/paracetamol) and an NSAID (bromfenac) on driving ability, memory functioning, psychomotor performance, pupil size, and mood.
Journal: The Clinical journal of pain 20060601
Title: Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium.
Journal: Current medical research and opinion 20060601
Title: A systematic review of NSAIDs withdrawn from the market due to hepatotoxicity: lessons learned from the bromfenac experience.
Journal: Pharmacoepidemiology and drug safety 20060401
Title: Hy's law: predicting serious hepatotoxicity.
Journal: Pharmacoepidemiology and drug safety 20060401
Title: How can 'Hy's law' help the clinician?
Journal: Pharmacoepidemiology and drug safety 20060401
Title: Three cases of corneal melting after instillation of a new nonsteroidal anti-inflammatory drug.
Journal: Cornea 20060201
Title: Global experience with Xibrom (bromfenac ophthalmic solution) 0.09%: the first twice-daily ophthalmic nonsteroidal anti-inflammatory drug.
Journal: International ophthalmology clinics 20060101
Title: New drugs and dosage forms.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20050501
Title: Comparison of 0.1% bromfenac sodium and 0.1% pemirolast potassium for the treatment of allergic conjunctivitis.
Journal: Japanese journal of ophthalmology 20040101
Title: Effects of nonsteroidal anti-inflammatory drugs on experimental allergic conjunctivitis in Guinea pigs.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20031201
Title: Drug-induced hepatotoxicity.
Journal: The New England journal of medicine 20030731
Title: Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost.
Journal: The British journal of ophthalmology 20030301
Title: Serious liver injury. Leading reason for drug removals, restrictions.
Journal: FDA consumer 20010101
Title: Structure toxicity relationships--how useful are they in predicting toxicities of new drugs?
Journal: Advances in experimental medicine and biology 20010101
Title: Bromfenac (Duract)-associated hepatic failure requiring liver transplantation.
Journal: The American journal of gastroenterology 19990801
